SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic Test
Short Name: SMARCE1 Meningioma NGS Test
Also known as: SMARCE1 meningioma genetic test, Familial meningioma susceptibility test, SMARCE1 gene mutation analysis
SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS Technology on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
To identify mutations in the SMARCE1 gene for early detection, diagnosis, and management of familial meningioma susceptibility, enabling informed medical decisions and family planning.
- Test Code
- 2897
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 Weeks
- Fasting Required
- No
- Method
- NGS Technology
Sample Collection
No specific preparation required. Provide clinical history and family pedigree chart as advised.
Method: Venipuncture or DNA extraction
Laboratory Analysis
Blood sample will be drawn by a trained phlebotomist. For DNA extraction, follow lab instructions.
Report Delivery
Apply pressure to the puncture site. Resume normal activities. Store samples as per instructions if self-collected.
Timeline: 3 to 4 Weeks
Patient Instructions
About This Test
Who Should Get This Test
To identify mutations in the SMARCE1 gene for early detection, diagnosis, and management of familial meningioma susceptibility, enabling informed medical decisions and family planning.
How to Prepare
- Use sterile equipment
- Label samples correctly
- Transport at ambient temperature unless specified
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Genetic testing for SMARCE1 mutations is crucial for early detection and management of familial meningioma, especially in individuals with a family history or symptoms."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed samples
- Insufficient volume
- Improper labeling
Understanding Your Results
Positive for pathogenic variant
Increased risk for familial meningioma. Clinical correlation and family screening advised.
Negative for pathogenic variant
No mutation detected. Risk may not be eliminated; consider other genetic or environmental factors.
Variant of uncertain significance
Further testing or family studies may be needed for clarification.
Consult a healthcare professional if you have a family history of meningioma, experience symptoms like headaches or seizures, or receive a positive test result for further management and genetic counseling.
Limitations
- ⚠May not detect all genetic variants or mutations
- ⚠Results require clinical correlation
- ⚠Does not replace imaging or other diagnostic methods
Risks & Considerations
- ●Minimal risks from blood draw, such as bruising or infection
- ●Psychological impact of genetic results
Interfering Factors
- ●Poor sample quality
- ●Contaminated DNA
- ●Recent blood transfusions
Frequently Asked Questions
What is SMARCE1 gene meningioma?
How is the NGS genetic test performed?
What is the cost of the SMARCE1 gene meningioma NGS test in India?
Is home sample collection available?
How long does it take to get results?
What are the symptoms of SMARCE1 gene meningioma?
Is the test covered by insurance?
Can children undergo this genetic test?
What if the test result is positive?
How accurate is NGS testing for SMARCE1 mutations?
Do I need a doctor's referral for this test?
What is the inheritance pattern of SMARCE1 gene meningioma?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
